A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : SBRT / stereotactic body radiation therapy

[Related PubMed/MEDLINE]
Total Number of Papers: 3959
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   SBRT  (>> Co-occurring Abbreviation)
Long Form:   stereotactic body radiation therapy
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 A retrospective study to establish recommendations for plan quality metrics in Lung SBRT. ICRU, RTOG
2022 Accuracy evaluation of surface registration algorithm using normal distribution transform in stereotactic body radiotherapy/radiosurgery: A phantom study. ICP, NDT, RMS, SRS
2022 Clinical Values and Markers of Radiation-Induced Liver Disease for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Treated With Stereotactic Body Radiotherapy. HCC, PVTT, RILD
2022 Computed tomography-based radiomic model predicts radiological response following stereotactic body radiation therapy in early-stage non-small-cell lung cancer and pulmonary oligo-metastases. CI, CR, CT, GTV, NSCLC, PR, SVM
2022 Dosimetric impact of interfraction prostate and seminal vesicle volume changes and rotation: A post-hoc analysis of a phase III randomized trial of MRI-guided versus CT-guided stereotactic body radiotherapy. SVs
2022 Dynamic hybrid-phase computed tomography simulation in lung stereotactic body radiotherapy: A feasibility study. CBCT, CTDHP, DSC, ITV, PTV, VO
2022 Effect of systemic inflammation biomarkers on overall survival after lung cancer radiotherapy: a single-center large-cohort study. HR, NLR, NSCLC, OS, PLR, RT, SCLC, SII
2022 Efficacy and Safety of Reirradiation with Stereotactic Body Radiation Therapy for Locally Recurrent Pancreatic Adenocarcinoma. LPFS, PFS
2022 Evaluation of patient-specific motion management for radiotherapy planning computed tomography using a statistical method. CBCT, CT, LG, MPCT, UG, VMAT
10  2022 Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation. AUC, CF-RT
11  2022 Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resection. BRPC, CI, HR, LAPC, MVA, TRG, UVA
12  2022 Presence of tumour capsule on contrast-enhanced CT is associated with improved outcomes of stereotactic body radiation therapy in hepatocellular carcinoma patients. CT, HCC, mRECIST, ORR, OS, RECIST
13  2022 Re-irradiation after stereotactic body radiotherapy for spine metastases from hepatocellular carcinoma: a case report. OAR
14  2022 Stereotactic Body Radiotherapy and Conventional Radiotherapy Induce Cytoskeleton Extension and Enlargement of Cell Morphology in Non-Small Cell Lung Cancer. BED, CRT, NSCLC
15  2022 Stereotactic body radiotherapy-induced abscopal effect twice after pembrolizumab failure in hereditary leiomyomatosis and renal cell carcinoma: a case report with genetic and immunologic analysis. HLRCC, ICIs, RPLN
16  2021 5-year results of accelerated partial breast irradiation (APBI) with SBRT (stereotactic body radiation therapy) and exactrac adaptive gating (Novalis) for very early breast cancer patients: was it all worth it? APBI, LINAC, PTV
17  2021 A case report of successful elimination of recurrent ventricular tachycardia by repeated stereotactic radiotherapy: the importance of accurate target volume delineation. VTs
18  2021 A data-driven approach to optimal beam/arc angle selection for liver stereotactic body radiation therapy treatment planning. IGRT, PTV
19  2021 A deep survival interpretable radiomics model of hepatocellular carcinoma patients. CE, CNN, DNN, HCC, OS, VAE
20  2021 A multi-institutional analysis of fractionated versus single-fraction stereotactic body radiotherapy (SBRT) in the treatment of primary lung tumors: a comparison between two antipodal fractionations. CSS, OS, SF, TF
21  2021 A narrative review of invasive diagnostics and treatment of early lung cancer. GGO, NSCLC, VDT
22  2021 A narrative review of oligometastatic prostate cancer-an evolving paradigm. ADT, MDT, OMPC, OS
23  2021 A national cancer database analysis on stereotactic body radiation therapy of head and neck cancers. BED, BED10, CI, HNC, HR
24  2021 A novel CRT-IMRT-combined (Co-CRIM) planning technique for peripheral lung stereotactic body radiotherapy in pinnacle treatment planning system. CI, Co-CRIM, CRT, GI, HI, IMRT, ITV, MU, TPS, VMAT
25  2021 A Novel Proton Pencil Beam Scanning FLASH RT Delivery Method Enables Optimal OAR Sparing and Ultra-High Dose Rate Delivery: A Comprehensive Dosimetry Study for Lung Tumors. ADR, DADR, DTDR, OAR
26  2021 A novel restricted single-isocenter stereotactic body radiotherapy (RESIST) method for synchronous multiple lung lesions to minimize setup uncertainties. CBCT, DCA, RESIST, VMAT
27  2021 A patient with metastatic non-small cell lung cancer who received pembrolizumab monotherapy after stereotactic body radiotherapy had progression-free survival of nearly 5 years: a case report. NSCLC, PFS, SABR, TPS
28  2021 A patient-specific QA comparison between 2D and 3D diode arrays for single-lesion SRS and SBRT treatments. DCAT, PSQA, SRS, VMAT
29  2021 A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study. ---
30  2021 A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma. BRPC, IORT
31  2021 A propensity-matched analysis of stereotactic body radiotherapy and sublobar resection for stage I non-small cell lung cancer in patients at high risk for lobectomy: the results in a Chinese population. CSS, FEV1, LC, NSCLC, OS, PSM, SLR
32  2021 A Propensity-Matched Analysis of Survival of Clinically Diagnosed Early-Stage Lung Cancer and Biopsy-Proven Early-Stage Non-Small Cell Lung Cancer Following Stereotactic Ablative Radiotherapy. LC, OS, PFS, PSM
33  2021 A Prospective Trial Evaluating the Safety and Systemic Response From the Concurrent Use of Radiation Therapy with Checkpoint Inhibitor Immunotherapy in Metastatic Non-Small Cell Lung Cancer. CPI, ORR
34  2021 A prospective trial of stereotactic body radiation therapy for unresectable pancreatic cancer testing ablative doses. DLT, FFLF, GI, MTD, PTV, RT
35  2021 A protocol for absolute dose verification of SBRT/SRS treatment plans using Gafchromic™ EBT-XD films. SRS, TH
36  2021 A single institutional experience with central lung stereotactic body radiation therapy demonstrating encouraging results with increased inter-fraction time. COPD, NSCLC
37  2021 A survey of the practice of stereotactic body radiotherapy for hepatocellular and pancreatic malignancies in India. HCC
38  2021 A unified multi-activation (UMA) model of cell survival curves over the entire dose range for calculating equivalent doses in stereotactic body radiation therapy (SBRT), high dose rate brachytherapy (HDRB), and stereotactic radiosurgery (SRS). HDRB, LQ, SRS, UMA
39  2021 A Volumetric Dosimetry Analysis of Vertebral Body Fracture Risk After Single Fraction Spine Stereotactic Body Radiation Therapy. VCF
40  2021 Ablative radiosurgery for cardiac arrhythmias-A systematic review. ---
41  2021 Ablative Radiotherapy for Liver Tumors Using Stereotactic MRI-Guidance: A Prospective Phase I Trial. MR-Co, MRgRT, OS
42  2021 Acceptance procedure for the linear accelerator component of the 1.5 T MRI-linac. IGRT, kV
43  2021 Account for the Full Extent of Esophagus Motion in Radiation Therapy Planning: A Preliminary Study of the IRV of the Esophagus. AVG, CT, MIP, PRV, U4D
44  2021 Acute side effects after definitive stereotactic body radiation therapy (SBRT) for patients with clinically localized or locally advanced prostate cancer: a single institution prospective study. GI, GU, IMRT, RTOG, SIB
45  2021 Adrenal Pheochromocytoma Treated With Stereotactic Body Radiation Therapy. EBRT
46  2021 Advanced radiotherapy technique in hepatocellular carcinoma with portal vein thrombosis: Feasibility and clinical outcomes. 3DCRT, BED, HCC, IMRT, LC, OS, PVTT, RT, VMAT
47  2021 Age-related treatment patterns for stage I NSCLC in three European countries. NSCLC
48  2021 AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer. IPC, POPC
49  2021 Alternative methods for local ablation-interventional pulmonology: a narrative review. MWA, RFA
50  2021 An analysis of a large multi-institutional database reveals important associations between treatment parameters and clinical outcomes for stereotactic body radiotherapy (SBRT) of oligometastatic colorectal cancer. CRC, OS
51  2021 An Analysis of Clinical Toxic Effects and Quality of Life as a Function of Radiation Dose and Volume After Lung Stereotactic Body Radiation Therapy. DFS, FACT-L-TOI, LC, NSCLC, OS, QoL
52  2021 Analysis of Hepatocellular Carcinoma Stereotactic Body Radiation Therapy Dose Prescription Method Using Uncomplicated Tumor Control Probability Model. EUD, HCC, TCP, UTCE, UTCP
53  2021 Analysis of the amplitude changes and baseline shifts of respiratory motion using intra-fractional CBCT in liver stereotactic body radiation therapy. AP, CBCT, LR, SI
54  2021 Analysis of using high-precision radiotherapy in the treatment of liver metastases regarding toxicity and survival. CT
55  2021 Androgen Receptor Targeted Therapy + Radiotherapy in Metastatic Castration Resistant Prostate Cancer. 3DCRT, ARTT, mCRPC, MDT, OS, PFS
56  2021 Anemia is a Prognostic Factor for Overall Survival Rate in Patients with Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy. Hb, LC, NSCLC, OS
57  2021 Approach to Oligometastatic Cancer in the Elderly Patient. OMD
58  2021 Are older patients with non-small cell lung cancer receiving optimal care? A population-based study. NSCLC
59  2021 Assessing the robustness of artificial intelligence powered planning tools in radiotherapy clinical settings-a phantom simulation approach. AI, CRA, OAR, SIB, TPS
60  2021 Assessment of HDR brachytherapy-replicating prostate radiotherapy planning for tomotherapy, cyberknife and VMAT. CK, EBRT, HDR BT, IC, MLC, OARs, PTV, TOMO, TPS, VMAT
61  2021 Assessment of IGRT variability for lung SBRT. kV-CBCT, ROs, RTTs
62  2021 Auto-delineation framework for the focal liver reaction observed in post Stereotactic Body Radiation Therapy (SBRT) Primovist MRI scans. CNR, COM
63  2021 Automated approach for segmenting gross tumor volumes for lung cancer stereotactic body radiation therapy using CT-based dense V-networks. CT, DSC, DVNs, GTVs, HD, ROI
64  2021 Automated Non-Coplanar VMAT for Dose Escalation in Recurrent Head and Neck Cancer Patients. GTV, NTCP, OAR, PTV, rHNC, TCP, VMAT
65  2021 Automated robust SBPT planning using EUD-based prediction of SBRT plan for patients with lung cancer. RSBPT
66  2021 Automation and integration of a novel restricted single-isocenter stereotactic body radiotherapy (a-RESIST) method for synchronous two lung lesions. a-RESIST, CBCT, m-RESIST, RESIST, VMAT
67  2021 Benefit of replanning in MR-guided online adaptive radiation therapy in the treatment of liver metastasis. GTV, IQR, OARs, PTV, RP, sBP
68  2021 Bi/Se-Based Nanotherapeutics Sensitize CT Image-Guided Stereotactic Body Radiotherapy through Reprogramming the Microenvironment of Hepatocellular Carcinoma. HCC, Len, NPs, RT
69  2021 Bibliometric Analysis of the Top-Cited Publications and Research Trends for Stereotactic Body Radiotherapy. ---
70  2021 Bothersome Hematospermia Following Stereotactic Body Radiation Therapy for Prostate Cancer. QoL
71  2021 Calculation algorithms and penumbra: Underestimation of dose in organs at risk in dosimetry audits. AAA, ACDS, AXB, LBTE, MC, OARs
72  2021 Cardiac stereotactic body radiation therapy for ventricular tachycardia: Current experience and technical gaps. ---
73  2021 Case Report: First in Human Online Adaptive MR Guided SBRT of Peritoneal Carcinomatosis Nodules: A New Therapeutic Approach for the Oligo-Metastatic Patient. MRgRT, OA, PC
74  2021 Case Report: Metastatic Parosteal Osteosarcoma in a Dog. CT, POSA
75  2021 Case series on stereotactic body radiation therapy in non-ischemic cardiomyopathy patients with recurrent ventricular tachycardia. ATP, NICM, VT
76  2021 CCTG SC.24/TROG 17.06: A Randomized Phase II/III Study Comparing 24Gy in 2 Stereotactic Body Radiotherapy (SBRT) Fractions Versus 20Gy in 5 Conventional Palliative Radiotherapy (CRT) Fractions for Patients with Painful Spinal Metastases. CRT
77  2021 Changes in pulmonary function and their correlation with dose-volume parameters in patients undergoing stereotactic body radiotherapy for lung cancer. FEV1, FVC, PFTs, PTV
78  2021 Changing pattern of radiation therapy for bone metastases in an Australian population-based cohort of men with prostate cancer. ART, BM, PCa, SF-RT, VRMDS
79  2021 Characterisation of a synthetic diamond detector for end-to-end dosimetry in stereotactic body radiotherapy and radiosurgery. SRS
80  2021 Characteristics Assessment of Online YouTube Videos on Radiotherapy for Lung Cancer. SABR
81  2021 Charged Particle and Conventional Radiotherapy: Current Implications as Partner for Immunotherapy. ICI, PRT, RT
82  2021 Charlson comorbidity index and G8 in older old adult(≥80years) hepatocellular carcinoma patients treated with stereotactic body radiotherapy. CCI, CGA, HCC, LC, OS, PFS
83  2021 Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial. CPIs
84  2021 Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastases. PTV, SBM, VCF
85  2021 Clinical Effects of Stereotactic Body Radiation Therapy Targeting the Primary Tumor of Liver-Only Oligometastatic Pancreatic Cancer. OS, PFS
86  2021 Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case series. HCC, LT, OS, RFS, RILD
87  2021 Clinical Outcomes and Prognostic Factors of Salvage Stereotactic Body Radiotherapy for Post-Surgical Thoracic Oligo-Recurrence/Metastasis of Non-Small-Cell Lung Cancer. CCI, CK, LC, NLCLC, NLR, OS, PFS
88  2021 Clinical Outcomes and Safety Profile in the Treatment of Synchronous Non-Metastatic Lung Tumors with Stereotactic Body Radiotherapy. DF, LF, NP, OS, SPLC
89  2021 Clinical outcomes of stereotactic magnetic resonance image-guided adaptive radiotherapy for primary and metastatic tumors in the abdomen and pelvis. LC, OS, PFS, SMART
90  2021 Clinical utility of Gafchromic film in an MRI-guided linear accelerator. SEM
91  2021 Combination of Sorafenib, Camrelizumab, Transcatheter Arterial Chemoembolization, and Stereotactic Body Radiation Therapy as a Novel Downstaging Strategy in Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Case Series Study. HCC, OS, PFS, PVTT, TACE
92  2021 Combination of yttrium-90 radioembolization with stereotactic body radiation therapy in the treatment of portal vein tumor thrombosis. OS, PV, PVTT
93  2021 Combining computed tomography and biologically effective dose in radiomics and deep learning improves prediction of tumor response to robotic lung stereotactic body radiation therapy. AUC, BED, CT, DL, DLCT,BED, ML, NSCLC, RadCT, RadCT,BED
94  2021 Combining Stereotactic Body Radiotherapy and Microwave Ablation Appears Safe and Feasible for Renal Cell Carcinoma in an Early Series. MW, RCC
95  2021 Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma. CI, CN, HDR, HDR BT, HTCI
96  2021 Comparison of Oncologic Outcomes between Carbon Ion Radiotherapy and Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer. CIRT, HR, LC, NSCLC, OS
97  2021 Comparison of Phase-Gated and Amplitude-Gated Dose Delivery to a Moving Target using Gafchromic EBT3 Film. DCAT, GTV, MU, tt
98  2021 Comparison of stereotactic body radiation therapy versus fractionated radiation therapy for primary liver cancer with portal vein tumor thrombus. FRT, PVTT
99  2021 Comparison of stereotactic body radiotherapy and radiofrequency ablation for hepatocellular carcinoma: Systematic review and meta-analysis of propensity score studies. HCC, HRs, LC, OS, PSMS, RFA
100  2021 Comparison of technical success and safety of transbronchial versus percutaneous CT-guided fiducial placement for SBRT of lung tumors. ---